Cingulate (CING) Earnings Date & Reports

Cingulate Inc is a clinical-stage biopharmaceutical company focused on the development of products utilizing its drug delivery platform technology that enables the formulation and manufacture of once-daily tablets of multi-dose therapies, with an initial focus on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

CING is expected to report earnings to fall 33.34% to -63 cents per share on August 18

Q2'26

Est.

$-0.63

Q1'26

Missed

by $0.47

Q4'25

Est.

$-0.93

Q3'25

Missed

by $0.40

Q2'25

Missed

by $0.16

The last earnings report on May 14 showed earnings per share of -94 cents, missing the estimate of -47 cents. With 77.97K shares outstanding, the current market capitalization sits at 66.54M.

View a ticker or compare two or three

Compare

CING

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for CING